These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 28857256)
1. Autophagy-dependent crosstalk between GILT and PAX-3 influences radiation sensitivity of human melanoma cells. Hathaway-Schrader JD; Doonan BP; Hossain A; Radwan FFY; Zhang L; Haque A J Cell Biochem; 2018 Feb; 119(2):2212-2221. PubMed ID: 28857256 [TBL] [Abstract][Full Text] [Related]
2. Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Goldstein OG; Hajiaghamohseni LM; Amria S; Sundaram K; Reddy SV; Haque A Cancer Immunol Immunother; 2008 Oct; 57(10):1461-70. PubMed ID: 18343923 [TBL] [Abstract][Full Text] [Related]
3. Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma. Nguyen J; Bernert R; In K; Kang P; Sebastiao N; Hu C; Hastings KT Melanoma Res; 2016 Apr; 26(2):125-37. PubMed ID: 26930048 [TBL] [Abstract][Full Text] [Related]
4. GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition. Hathaway-Schrader JD; Norton D; Hastings K; Doonan BP; Fritz ST; Bethard JR; Blum JS; Haque A Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162988 [TBL] [Abstract][Full Text] [Related]
5. Cutting edge: induction of the antigen-processing enzyme IFN-gamma-inducible lysosomal thiol reductase in melanoma cells Is STAT1-dependent but CIITA-independent. O'Donnell PW; Haque A; Klemsz MJ; Kaplan MH; Blum JS J Immunol; 2004 Jul; 173(2):731-5. PubMed ID: 15240658 [TBL] [Abstract][Full Text] [Related]
6. High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma. Buetow KH; Meador LR; Menon H; Lu YK; Brill J; Cui H; Roe DJ; DiCaudo DJ; Hastings KT J Immunol; 2019 Nov; 203(10):2577-2587. PubMed ID: 31591149 [TBL] [Abstract][Full Text] [Related]
7. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins. Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658 [TBL] [Abstract][Full Text] [Related]
8. Identification of three IFN-γ inducible lysosomal thiol reductase (GILT)-like genes in mud crab Scylla paramamosain with distinct gene organizations and patterns of expression. Huang WS; Duan LP; Huang B; Zhou LH; Liang Y; Tu CL; Zhang FF; Nie P; Wang T Gene; 2015 Oct; 570(1):78-88. PubMed ID: 26051415 [TBL] [Abstract][Full Text] [Related]
9. Diverse cellular and organismal functions of the lysosomal thiol reductase GILT. Rausch MP; Hastings KT Mol Immunol; 2015 Dec; 68(2 Pt A):124-8. PubMed ID: 26116226 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and expression analysis of interferon-gamma-inducible lysosomal thiol reductase (GILT) gene from pearl oyster Pinctada fucata. Zhang D; Pan D; Cui S; Su T; Qiu L; Zhu C; Jiang S Dev Comp Immunol; 2010 Sep; 34(9):969-76. PubMed ID: 20444427 [TBL] [Abstract][Full Text] [Related]
11. Absence of gamma-interferon-inducible lysosomal thiol reductase (GILT) is associated with poor disease-free survival in breast cancer patients. Xiang YJ; Guo MM; Zhou CJ; Liu L; Han B; Kong LY; Gao ZC; Ma ZB; Wang L; Feng M; Chen HY; Jia GT; Gao DZ; Zhang Q; Li L; Li YY; Yu ZG PLoS One; 2014; 9(10):e109449. PubMed ID: 25333930 [TBL] [Abstract][Full Text] [Related]
12. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Muratovska A; Zhou C; He S; Goodyer P; Eccles MR Oncogene; 2003 Sep; 22(39):7989-97. PubMed ID: 12970747 [TBL] [Abstract][Full Text] [Related]
13. GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity. Phipps-Yonas H; Semik V; Hastings KT Eur J Immunol; 2013 Jan; 43(1):65-74. PubMed ID: 23012103 [TBL] [Abstract][Full Text] [Related]
14. The first echinoderm gamma-interferon-inducible lysosomal thiol reductase (GILT) identified from sea cucumber (Stichopus monotuberculatus). Ren C; Chen T; Jiang X; Luo X; Wang Y; Hu C Fish Shellfish Immunol; 2015 Jan; 42(1):41-9. PubMed ID: 25449705 [TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of a gamma-interferon-inducible lysosomal thiol reductase homolog from guinea pig (Cavia porcellus) that exhibits thiol reductase activity in vitro. Ma L; Cao F; Tang R; Zhang J; Zhang S Res Vet Sci; 2017 Apr; 111():81-84. PubMed ID: 28064023 [TBL] [Abstract][Full Text] [Related]
16. Molecular structure, phylogenetic analysis, tissue distribution, and function characterization of interferon-γ-inducible lysosomal thiol reductase (GILT) gene in sheep (Ovis aries). Ai HX; Zhang ZZ; Shen YF; Zhang JX; Zhou XM; Min C; Zhu SY; Zhang SQ Vet Immunol Immunopathol; 2011 Apr; 140(3-4):329-34. PubMed ID: 21334075 [TBL] [Abstract][Full Text] [Related]
17. Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase. Hastings KT; Cresswell P Antioxid Redox Signal; 2011 Aug; 15(3):657-68. PubMed ID: 21506690 [TBL] [Abstract][Full Text] [Related]
18. Identification of interferon-γ-inducible-lysosomal thiol reductase (GILT) gene in goldfish (Carassius auratus) and its immune response to LPS challenge. Li JF; Li J; Wang ZG; Liu HZ; Zhao YL; Zhang JX; Zhang SQ; Liu JP Fish Shellfish Immunol; 2015 Feb; 42(2):465-72. PubMed ID: 25447639 [TBL] [Abstract][Full Text] [Related]
19. Signal transducer and activator of transcription 1 negatively regulates constitutive gamma interferon-inducible lysosomal thiol reductase expression. Srinivasan P; Maric M Immunology; 2011 Feb; 132(2):209-16. PubMed ID: 21039465 [TBL] [Abstract][Full Text] [Related]
20. miR-638 promotes melanoma metastasis and protects melanoma cells from apoptosis and autophagy. Bhattacharya A; Schmitz U; Raatz Y; Schönherr M; Kottek T; Schauer M; Franz S; Saalbach A; Anderegg U; Wolkenhauer O; Schadendorf D; Simon JC; Magin T; Vera J; Kunz M Oncotarget; 2015 Feb; 6(5):2966-80. PubMed ID: 25650662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]